Cargando…

Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage

BACKGROUND: Pyroptosis is a programmed cell death mediated by inflammasomes. Previous studies have reported that inhibition of neurokinin receptor 1 (NK1R) exerted neuroprotection in several neurological diseases. Herein, we have investigated the role of NK1R receptor inhibition using Aprepitant to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Peng, Qi, Dongqing, Cui, Yuhui, Lenahan, Cameron, Zhang, John H., Tao, Xiaogen, Deng, Shuixiang, Tang, Jiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351153/
https://www.ncbi.nlm.nih.gov/pubmed/35922848
http://dx.doi.org/10.1186/s12974-022-02558-z
_version_ 1784762379477712896
author Jin, Peng
Qi, Dongqing
Cui, Yuhui
Lenahan, Cameron
Zhang, John H.
Tao, Xiaogen
Deng, Shuixiang
Tang, Jiping
author_facet Jin, Peng
Qi, Dongqing
Cui, Yuhui
Lenahan, Cameron
Zhang, John H.
Tao, Xiaogen
Deng, Shuixiang
Tang, Jiping
author_sort Jin, Peng
collection PubMed
description BACKGROUND: Pyroptosis is a programmed cell death mediated by inflammasomes. Previous studies have reported that inhibition of neurokinin receptor 1 (NK1R) exerted neuroprotection in several neurological diseases. Herein, we have investigated the role of NK1R receptor inhibition using Aprepitant to attenuate NLRC4-dependent neuronal pyroptosis after intracerebral hemorrhage (ICH), as well as the underlying mechanism. METHODS: A total of 182 CD-1 mice were used. ICH was induced by injection of autologous blood into the right basal ganglia. Aprepitant, a selective antagonist of NK1R, was injected intraperitoneally at 1 h after ICH. To explore the underlying mechanism, NK1R agonist, GR73632, and protein kinase C delta (PKCδ) agonist, phorbol 12-myristate 13-acetate (PMA), were injected intracerebroventricularly at 1 h after ICH induction, and small interfering ribonucleic acid (siRNA) for NLRC4 was administered via intracerebroventricular injection at 48 h before ICH induction, respectively. Neurobehavioral tests, western blot, and immunofluorescence staining were performed. RESULTS: The expression of endogenous NK1R and NLRC 4 were gradually increased after ICH. NK1R was expressed on neurons. Aprepitant significantly improved the short- and long-term neurobehavioral deficits after ICH, which was accompanied with decreased neuronal pyroptosis, as well as decreased expression of NLRC4, Cleaved-caspase-1, GSDMD (gasdermin D), IL-1β, and IL-18. Activation of NK1R or PKCδ abolished these neuroprotective effects of Aprepitant after ICH. Similarly, knocking down NLRC4 using siRNA produced similar neuroprotective effects. CONCLUSION: Aprepitant suppressed NLRC4-dependent neuronal pyroptosis and improved neurological function, possibly mediated by inhibition of NK1R/PKCδ signaling pathways after ICH. The NK1R may be a promising therapeutic target for the treatment of ICH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-022-02558-z.
format Online
Article
Text
id pubmed-9351153
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93511532022-08-05 Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage Jin, Peng Qi, Dongqing Cui, Yuhui Lenahan, Cameron Zhang, John H. Tao, Xiaogen Deng, Shuixiang Tang, Jiping J Neuroinflammation Research BACKGROUND: Pyroptosis is a programmed cell death mediated by inflammasomes. Previous studies have reported that inhibition of neurokinin receptor 1 (NK1R) exerted neuroprotection in several neurological diseases. Herein, we have investigated the role of NK1R receptor inhibition using Aprepitant to attenuate NLRC4-dependent neuronal pyroptosis after intracerebral hemorrhage (ICH), as well as the underlying mechanism. METHODS: A total of 182 CD-1 mice were used. ICH was induced by injection of autologous blood into the right basal ganglia. Aprepitant, a selective antagonist of NK1R, was injected intraperitoneally at 1 h after ICH. To explore the underlying mechanism, NK1R agonist, GR73632, and protein kinase C delta (PKCδ) agonist, phorbol 12-myristate 13-acetate (PMA), were injected intracerebroventricularly at 1 h after ICH induction, and small interfering ribonucleic acid (siRNA) for NLRC4 was administered via intracerebroventricular injection at 48 h before ICH induction, respectively. Neurobehavioral tests, western blot, and immunofluorescence staining were performed. RESULTS: The expression of endogenous NK1R and NLRC 4 were gradually increased after ICH. NK1R was expressed on neurons. Aprepitant significantly improved the short- and long-term neurobehavioral deficits after ICH, which was accompanied with decreased neuronal pyroptosis, as well as decreased expression of NLRC4, Cleaved-caspase-1, GSDMD (gasdermin D), IL-1β, and IL-18. Activation of NK1R or PKCδ abolished these neuroprotective effects of Aprepitant after ICH. Similarly, knocking down NLRC4 using siRNA produced similar neuroprotective effects. CONCLUSION: Aprepitant suppressed NLRC4-dependent neuronal pyroptosis and improved neurological function, possibly mediated by inhibition of NK1R/PKCδ signaling pathways after ICH. The NK1R may be a promising therapeutic target for the treatment of ICH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-022-02558-z. BioMed Central 2022-08-03 /pmc/articles/PMC9351153/ /pubmed/35922848 http://dx.doi.org/10.1186/s12974-022-02558-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jin, Peng
Qi, Dongqing
Cui, Yuhui
Lenahan, Cameron
Zhang, John H.
Tao, Xiaogen
Deng, Shuixiang
Tang, Jiping
Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage
title Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage
title_full Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage
title_fullStr Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage
title_full_unstemmed Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage
title_short Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage
title_sort aprepitant attenuates nlrc4-dependent neuronal pyroptosis via nk1r/pkcδ pathway in a mouse model of intracerebral hemorrhage
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351153/
https://www.ncbi.nlm.nih.gov/pubmed/35922848
http://dx.doi.org/10.1186/s12974-022-02558-z
work_keys_str_mv AT jinpeng aprepitantattenuatesnlrc4dependentneuronalpyroptosisviank1rpkcdpathwayinamousemodelofintracerebralhemorrhage
AT qidongqing aprepitantattenuatesnlrc4dependentneuronalpyroptosisviank1rpkcdpathwayinamousemodelofintracerebralhemorrhage
AT cuiyuhui aprepitantattenuatesnlrc4dependentneuronalpyroptosisviank1rpkcdpathwayinamousemodelofintracerebralhemorrhage
AT lenahancameron aprepitantattenuatesnlrc4dependentneuronalpyroptosisviank1rpkcdpathwayinamousemodelofintracerebralhemorrhage
AT zhangjohnh aprepitantattenuatesnlrc4dependentneuronalpyroptosisviank1rpkcdpathwayinamousemodelofintracerebralhemorrhage
AT taoxiaogen aprepitantattenuatesnlrc4dependentneuronalpyroptosisviank1rpkcdpathwayinamousemodelofintracerebralhemorrhage
AT dengshuixiang aprepitantattenuatesnlrc4dependentneuronalpyroptosisviank1rpkcdpathwayinamousemodelofintracerebralhemorrhage
AT tangjiping aprepitantattenuatesnlrc4dependentneuronalpyroptosisviank1rpkcdpathwayinamousemodelofintracerebralhemorrhage